Important Notice: Our web hosting provider recently started charging us for additional visits, which was unexpected. In response, we're seeking donations. Depending on the situation, we may explore different monetization options for our Community and Expert Contributors. It's crucial to provide more returns for their expertise and offer more Expert Validated Answers or AI Validated Answers. Learn more about our hosting issue here.

What is the likelihood that I will be categorized as More Likely to Respond?

categorized likely respond
0
10 Posted

What is the likelihood that I will be categorized as More Likely to Respond?

0
10

Approximately 20% of patients will have the genotype associated with increased likelihood of response to rituximab monotherapy for follicular, CD20-positive, B-cell NHL. Some patients who do not have the 158Val/Val genotype may still respond to rituximab treatment.

Related Questions

What is your question?

*Sadly, we had to bring back ads too. Hopefully more targeted.

Experts123